Literature DB >> 7561910

Cerebrospinal fluid.

E J Thompson1.   

Abstract

Mesh：

Year:  1995        PMID： 7561910      PMCID： PMC486067          DOI： 10.1136/jnnp.59.4.349

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  49 in total

1.  MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  D W Paty; J J Oger; L F Kastrukoff; S A Hashimoto; J P Hooge; A A Eisen; K A Eisen; S J Purves; M D Low; V Brandejs
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

2.  Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?

Authors:  K Felgenhauer; H J Schädlich; M Nekic; R Ackermann
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

3.  Improved outcome prediction based on CSF extrapolated creatine kinase BB isoenzyme activity and other risk factors in severe head injury.

Authors:  P Hans; A Albert; C Franssen; J Born
Journal:  J Neurosurg       Date:  1989-07       Impact factor: 5.115

4.  CSF neopterin as marker of disease activity in multiple sclerosis.

Authors:  S Fredrikson; H Link; P Eneroth
Journal:  Acta Neurol Scand       Date:  1987-05       Impact factor: 3.209

5.  Cyclosporin A curtails the progression of free light chain synthesis in the CSF of patients with multiple sclerosis.

Authors:  B N McLean; P Rudge; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

6.  Haem derivatives in the cerebrospinal fluid after intracranial haemorrhage.

Authors:  N G Wahlgren; C Lindquist
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

7.  Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

Authors:  R W Walker; E J Thompson; W I McDonald
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

8.  Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection.

Authors:  L Lindquist; T Linné; L O Hansson; M Kalin; G Axelsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 9.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

10.  The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.

Authors:  C Jacobi; H Reiber; K Felgenhauer
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849
View more
  11 in total

1.  Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.

Authors:  Meena U Rajagopal; Yetrib Hathout; Tobey J MacDonald; Mark W Kieran; Sri Gururangan; Susan M Blaney; Peter Phillips; Roger Packer; Heather Gordish-Dressman; Brian R Rood
Journal:  Proteomics       Date:  2011-01-27       Impact factor: 3.984

2.  CSF-Based Analysis for Identification of Potential Serum Biomarkers of Neural Tube Defects.

Authors:  Xinyu Yan; Lixin Mai; Changchun Lin; Wenji He; Gengsheng Yin; Jiakang Yu; Lian Huang; Sanqiang Pan
Journal:  Neurosci Bull       Date:  2017-07-10       Impact factor: 5.203

3.  Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice.

Authors:  Min Liu; David G Kuhel; Ling Shen; David Y Hui; Stephen C Woods
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-29       Impact factor: 3.619

4.  Insulin increases central apolipoprotein E levels as revealed by an improved technique for collection of cerebrospinal fluid from rats.

Authors:  Min Liu; Ling Shen; Denovan P Begg; David A D'alessio; Stephen C Woods
Journal:  J Neurosci Methods       Date:  2012-06-09       Impact factor: 2.390

5.  Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.

Authors:  Gurudutt Pendyala; Howard S Fox
Journal:  Genome Med       Date:  2010-03-30       Impact factor: 11.117

6.  Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.

Authors:  Gurudutt Pendyala; Sunia A Trauger; Ewa Kalisiak; Ronald J Ellis; Gary Siuzdak; Howard S Fox
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

7.  Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic.

Authors:  Nils von Neuhoff; Tonio Oumeraci; Thomas Wolf; Katja Kollewe; Peter Bewerunge; Boris Neumann; Benedikt Brors; Johannes Bufler; Ulrich Wurster; Brigitte Schlegelberger; Reinhard Dengler; Marc Zapatka; Susanne Petri
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease.

Authors:  Valerio Pisani; Alessandro Stefani; Mariangela Pierantozzi; Silvia Natoli; Paolo Stanzione; Diego Franciotta; Antonio Pisani
Journal:  J Neuroinflammation       Date:  2012-08-08       Impact factor: 8.322

9.  Neural differentiation of human umbilical cord mesenchymal stem cells by cerebrospinal fluid.

Authors:  Shirin Farivar; Zahra Mohamadzade; Reza Shiari; Alireza Fahimzad
Journal:  Iran J Child Neurol       Date:  2015

10.  Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.

Authors:  Richard Rubenstein; Binggong Chang
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.